Researchers developed an AI model to detect myocardial ischemia and coronary microvascular and vasomotor dysfunction using ...
GE HealthCare’s focus is on connecting equipment, software, and consumables into care pathways, and simplifying its operating ...
Launches Presidency with an Invitation: ‘Let’s Innovate Together!’ ...
Collaboration will combine Lexeo expertise in cardiac genetic medicine with Johnson & Johnson’s expertise in cardiovascular ...
About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...
Lexeo says the collaboration will accelerate the development of an unnamed preclinical cardiac gene therapy target.
A new study from Karolinska University Hospital and Karolinska Institutet in collaboration with Uppsala University Hospital ...
A new study from Karolinska University Hospital and Karolinska Institutet in collaboration with Uppsala University Hospital and Uppsala University ...
In recent years, interest has grown around two investigational peptides, BPC-157 and TB-500, proposed as part of a combined research-oriented protocol to explore tissue regeneration, angiogenesis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback